指南与共识皮肤肿瘤

口服普萘洛尔治疗增殖期婴儿血管瘤:英国儿童皮肤病学会共识指南

Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.
指南 / 共识 · Br J Dermatol · 2018-01-01

该共识针对口服普萘洛尔治疗婴儿血管瘤(IH)缺乏英国统一指南的现状,采用改良德尔菲法(国际治疗调查、系统证据综述、多学科专家组面对面会议和匿名投票)制定指南。专家组就8个类别的47条陈述达成共识,涵盖适应证与禁忌证、治疗前检查、起始与目标剂量、不良反应监测、PHACES综合征中的应用及停药方法。该指南旨在帮助英国统一和简化IH的口服普萘洛尔治疗并辅助临床决策。

要点

  • 共识涵盖口服普萘洛尔治疗IH的适应证、禁忌证、治疗前检查、剂量、监测、PHACES综合征应用及停药。
  • 采用改良德尔菲法,经国际治疗调查、系统证据综述、多学科专家组会议和匿名投票形成共识。
  • 专家组就8个类别共47条陈述达成共识,旨在统一和简化英国IH治疗。

核心结论

  • 该共识指南有助于在英国统一和简化口服普萘洛尔治疗婴儿血管瘤,并辅助临床决策。

研究设计与样本

  • 采用改良德尔菲技术,包括国际治疗调查、系统证据文献综述、面对面多学科专家组会议和匿名投票。

主要发现

  • 专家组就8个类别的47条陈述达成共识,包括开始普萘洛尔的适应证和禁忌证、治疗前检查、起始和目标剂量、不良反应监测、PHACES综合征中的使用及如何停药。

关键数值与推荐

  • 专家组就8个类别的47条陈述达成共识,包括开始普萘洛尔的适应证和禁忌证、治疗前检查、起始和目标剂量、不良反应监测、PHACES综合征中的使用及如何停药。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infantile haemangiomas (IH) are the most common vascular tumours of infancy. Despite their frequency and potential complications, there are currently no unified U.K. guidelines for the treatment of IH with propranolol. There are still uncertainties and diverse opinions regarding indications, pretreatment investigations, its use in PHACES (posterior fossa malformations-haemangiomas-arterial anomalies-cardiac defects-eye abnormalities-sternal cleft and supraumbilical raphe) syndrome and cessation of treatment. OBJECTIVES: To provide unified guidelines for the treatment of IH with propranolol. METHODS: This study used a modified Delphi technique, which involved an international treatment survey, a systematic evidence review of the literature, a face-to-face multidisciplinary panel meeting and anonymous voting. RESULTS: The expert panel achieved consensus on 47 statements in eight categories, including indications and contraindications for starting propranolol, pretreatment investigations, starting and target dose, monitoring of adverse effects, the use of propranolol in PHACES syndrome and how to stop treatment. CONCLUSIONS: These consensus guidelines will help to standardize and simplify the treatment of IH with oral propranolol across the U.K. and assist in clinical decision-making.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Solman L, Glover M, Beattie PE, et al. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. Br J Dermatol. 2018. PMID: 29774538. doi:10.1111/bjd.16779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。